Casa Sollievo della Sofferenza is a private scientific research hospital in San Giovanni Rotondo, Italy, founded by Saint Pio of Pietrelcina, and administered by Vatican City.

During the past decade, Casa Sollievo della Sofferenza, IRCCS conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Casa Sollievo della Sofferenza, IRCCS" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Casa Sollievo della Sofferenza IRCCS" with 2 trials sponsored, "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori" with 2 trials sponsored, "AVEO Pharmaceuticals, Inc." with 1 trials sponsored and "Alfasigma S.p.A." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Casa Sollievo della Sofferenza, IRCCS" #1 collaborator was "Casa Sollievo della Sofferenza IRCCS" with 2 trials as a collaborator, "Aria S.p.A." with 1 trials as a collaborator, "Associazione Revert ONLUS" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Dotsoft Olokliromenes Efarmoges Diadiktioy kai Vaseon Dedomenon AE" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Casa Sollievo della Sofferenza, IRCCS" are "Colitis, Ulcerative" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Carcinoma, Renal Cell" (1 trials), "Crohn's Disease" (1 trials) and "Elective Colonoscopy" (1 trials). Many other conditions were trialed in "Casa Sollievo della Sofferenza, IRCCS" in a lesser frequency.

Most popular intervention types in "Casa Sollievo della Sofferenza, IRCCS" are "Drug" (10 trials), "Other" (2 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abiraterone acetate (AA)" (1 trials), "BD4QoL platform" (1 trials), "Golimumab" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Casa Sollievo della Sofferenza, IRCCS" are 12 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Casa Sollievo della Sofferenza, IRCCS". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Casa Sollievo della Sofferenza, IRCCS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Casa Sollievo della Sofferenza, IRCCS, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Casa Sollievo della Sofferenza, IRCCS has several departments that took part in Clinical trials: "IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia" - 10 trials, "IRCCS Ospedale Casa Sollievo Della Sofferenza; SC Neurologia" - 2 trials, "IRCCS Ospedale Casa Sollievo della Soffenza; Stru Comp di Gastroenterologia ed Endoscopia digest" - 2 trials, "IRCCS Casa Sollievo Della Sofferenza; Unità Ricerca e Cura Huntington e Malattie Rare" - 2 trials, "Ospedale Casa Sollievo Della Sofferenza - Cardiologia - Utic - Riabil Cardiologica" - 2 trials